Business, energy, technology, markets and global industry news from Business News Today

European Investment Bank

Pharma & Biotech

MaaT Pharma’s PICASSO trial met its primary goal, so why is the melanoma efficacy picture still uncertain?

MaaT Pharma's PICASSO trial met its safety goal but showed similar melanoma responses. Discover what the results mean for MaaT034.

Read More
Medical Devices & Diagnostics

Tissium targets the nerve repair market with $68 million and a sutureless FDA-authorised device

Tissium has secured approximately $68 million to expand the U.S. rollout of Coaptium Connect, a light-activated polymer system for peripheral nerve repair. Its commercial opportunity is significant, but surgeon adoption and stronger comparative evidence remain crucial.

Read More